AIM2 and Alzheimer disease: In AD, AIM2 inflammasome was demonstrated to act as a mediator in microglial activation, Aβ deposition, and cytokine production, but the knockout of AIM2 in 5XFAD mice did not improve memory and anxiety phenotype or had any beneficial effect on cytokine expression (273).